An inhibitor of nitric oxide synthetase which has been shown to prevent glutamate toxicity. Nitroarginine has been experimentally tested for its ability to prevent ammonia toxicity and ammonia-induced alterations in brain energy and ammonia metabolites. (Neurochem Res 1995:200(4):451-6)
Nitroarginine has been studied across 24 research domains including ❤️ Cardiovascular, 🧠 Focus & Attention, 🔥 Metabolic, 🔬 Inflammation, 🦴 Bone & Joint. The primary research focus is ❤️ Cardiovascular with 16% of studies addressing this area.
The following compounds share molecular targets with Nitroarginine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.
This evidence profile for Nitroarginine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.
Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.